Nan Fung Group Holdings Ltd
Filing Date
Global Rank
#5,296
/ 8,607
▲ 353
· as of Mar 2026
Top Industry
Biotechnology
97.5%
3Y Alpha vs SPY
-18.3%
Period ended 3 months ago
Filed May 14, 2026 · 57d
20 quarters · since Jun 2021
Clone Performance
Jul 2023–Jul 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+7.2%
SPY
+77.0%
Annualised alpha
-18.6%
Max drawdown
−36.8%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
23 positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Top Position
27.3%
+5.2 pts
Top 5
68.4%
+9.5 pts
Top 10
83.5%
+3.5 pts
HHI
1,329
Diversified+317
Portfolio Trend
20 quarters · across all stocks
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 96.3% | $116,694,731 |
| Technology | 2.5% | $3,038,043 |
| Unclassified | 1.2% | $1,413,680 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
1 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| LBRX | Lb Pharmaceuticals Inc | +330,657 | 630,657 | $15,552,001 | |
| No positions match the current search. | |||||
Sold Out
Positions the filer fully exited
5 positions
23 positions ·
$121,146,454 total
· as of Mar 31, 2026
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| EVMN |
Evommune, Inc.
Healthcare
|
Held | 1,441,032 | $33,129,325 | 27.35% | |
| MPLT |
MapLight Therapeutics, Inc.
Healthcare
|
Held | 971,253 | $19,745,573 | 16.30% | |
| LBRX |
Lb Pharmaceuticals Inc
Healthcare
|
Added | 630,657 | $15,552,001 | 12.84% | |
| OCS |
Oculis Holding AG
Healthcare
|
Reduced | 350,745 | $9,326,309 | 7.70% | |
| INCY |
Incyte Corp
Healthcare
|
Reduced | 53,742 | $5,058,197 | 4.18% | |
| ONC |
BeOne Medicines Ltd.
Healthcare
|
Held | 15,722 | $4,668,962 | 3.85% | |
| RYTM |
Rhythm Pharmaceuticals, Inc.
Healthcare
|
Held | 49,120 | $4,271,966 | 3.53% | |
| CELC |
Celcuity Inc.
Healthcare
|
NEW | 28,300 | $3,230,162 | 2.67% | |
| ASND |
Ascendis Pharma A/S
Healthcare
|
Held | 13,600 | $3,110,728 | 2.57% | |
| PCOR |
Procore Technologies, Inc.
Technology
|
Held | 53,299 | $3,038,043 | 2.51% | |
| MDGL |
Madrigal Pharmaceuticals, Inc.
Healthcare
|
Reduced | 5,672 | $2,969,121 | 2.45% | |
| KYMR |
Kymera Therapeutics, Inc.
Healthcare
|
Held | 30,875 | $2,571,578 | 2.12% | |
| ACAD |
Acadia Pharmaceuticals Inc
Healthcare
|
Held | 102,984 | $2,292,423 | 1.89% | |
| HELP |
Cybin Inc.
Healthcare
|
Held | 460,000 | $2,208,000 | 1.82% | |
| ARGX |
Argenx SE
Healthcare
|
Held | 2,800 | $2,044,700 | 1.69% | |
| RVMD |
Revolution Medicines, Inc.
Healthcare
|
Held | 19,253 | $1,872,354 | 1.55% | |
| RXRX |
Recursion Pharmaceuticals, Inc.
Healthcare
|
Held | 595,287 | $1,827,531 | 1.51% | |
| INSM |
INSMED Inc
Healthcare
|
NEW | 6,580 | $1,075,961 | 0.89% | |
| ETHA |
iShares Ethereum Trust ETF
|
Held | 50,549 | $800,190 | 0.66% | |
| HRMY |
Harmony Biosciences Holdings, Inc.
Healthcare
|
Held | 27,049 | $757,642 | 0.63% | |
| TRDA |
Entrada Therapeutics, Inc.
Healthcare
|
Held | 49,082 | $619,414 | 0.51% | |
| IBIT |
iShares Bitcoin Trust ETF
|
Held | 15,968 | $613,490 | 0.51% | |
| RANI |
Rani Therapeutics Holdings, Inc.
Healthcare
|
Held | 493,584 | $362,784 | 0.30% |